Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation
Remarks:
in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study
Reference:
Composition 0
Qualifier:
according to
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
Qualifier:
according to
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
Qualifier:
according to
Guideline:
other: OPPTS 870.2600 (EPA)
Deviations:
no
Principles of method if other than guideline:
The modified Local Lymph Node Assay (IMDS) was performed on 24 female NMRI mice of the strain Hsd Win:NMRI (6 animals/test item group and 6 control animals) to determine if there is any specific (sensitizing) or non-specific (irritant) stimulating potential of the test item 1,3-dichlorobenzene.
A modification of the assay by measuring the cell counts instead of radioactive labeling provides comparable sensitivity, and has the advantage that the cell suspension can be further analyzed by different methods (flow cytometry, chemiluminescence responses, immunofluorescence) to gain an insight into mechanistic events. A further modification was done by including the measurement of the ear swelling after treatment leading to a much more simplified and reliable assay (Integrated Model for the Differentiation of Skin reactions (IMDS)). By comparing the specific immune reaction induced by the test item in the draining lymph nodes (LN; cell counts / LN weights) with the immediate unspecific acute skin reaction (ear swelling / ear weight) it is possible to discriminate the irritant potential from the sensitizing potential of the compound tested. International standards have been successfully determined using this modification. Such modifications are also authorized in the Note of Guidance SWP/2145/00 of the CPMP (2001) and OECD guideline 429.
With respect to this simple discrimination between sensitizing and irritant local reactions comparable findings have been reported in the human patch test system.
GLP compliance:
yes
Type of study:
mouse local lymphnode assay (LLNA)
Test material information:
Composition 1
Species:
mouse
Strain:
other: SPF-bred female NMRI mice of the strain Hsd Win:NMRI
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Nederland, Kreuzelweg 53, 5960 AD Horst, Netherland
- Age at study initiation: 9 weeks
- Weight at study initiation: 27 ¿ 35 grams
- Housing: During the adaptation period up to 8 mice were housed together in conventional Makrolon¿ type III cages. During the study period the animals were single-housed in type II cages.


- Diet (e.g. ad libitum): The feed, PROVIMI KLIBA SA 3883 maintenance diet for rats and mice (from Provimi Kliba SA, CH-4303 Kaiseraugst, Germany)

- Water (e.g. ad libitum): tap water (drinking bottles) were provided ad libitum.

- Acclimation period: After their arrival, the animals intended for the study were allowed to adapt to the conditions of the animal room for at least 6 days and their state of health was monitored


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2° C
- Humidity (%):40%-70%
- Air changes (per hr): About 10 changes per hour
- Photoperiod (hrs dark / hrs light): 12 h/12 h, with artificial illumi¬nation


IN-LIFE DATES: From: 19-10-2009 To: 22-10-2009
Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
0 (vehicle control), 2%, 10% or 50%.
No. of animals per dose:
6 animals
Details on study design:
TREATMENT PREPARATION AND ADMINISTRATION:
The test item was applied epicutaneously onto the dorsal part of both ears of the animals. This treatment was repeated on three consecutive days (d1, d2 and d3). The volume administered was 25 µl/ear.

Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
When it was statistically reasonable, the values from treated groups were compared with those from the control group(s; vehicle) by a one-way analysis of variance (ANOVA) [Mann and Whitney. Ann. Math. Stat. 18 (1947), 50-60; Wilcoxon. Biometrics 1 (1945), 80-83] when the variances are considered homogeneous according to a homogeneity testing like Cochran`s test [Sachs. Springer Verlag, Berlin (1978/2002)]. Alternatively, if the variances are considered to be heterogenous (p< or=0.05), a non-parametric Kruskal-Wallis test has been used (Kruskal-Wallis ANOVA) at significance levels of 5%. Two sided multiple test procedures were done according to Dunnett [Dunett . Ass. J. 50 (1955), 1096-1121; Dunett. Biometrics 20 (1964), 482-491] or Bonferroni-Holm [Holm. Scand. J. Statist. 6 (1979), 65-70], respectively. Outlying values in the LN weights were eliminated at a probability level of 99% by Nalimov's method [Keller, F. Statistik f. naturwissenschaftliche Berufe (1982), 88-89]. In addition, for the LLNA/IMDS the smallest significant differences in the means were calculated by Scheffe's method [Scheffe, H. Biometrica 40 (1953), 87-104 ], which according to Sachs [Sachs. Springer Verlag, Berlin (1978/2002)] can be used for both equal and unequal sample sizes.
In this method of statistical processing of measurements a large number of comparisons is made, and as a result of the multiple tests the overall probability of error is considerably greater than the p values suggest (increased number of false-positive results). On the other hand, the known methods of adjusting p values lead to an excessive increase in the number of false negatives. In view of these problems the biological and toxico¬logical relevance is also taken into consideration in the evaluation of statistical significance.

For this reason, in the case of indices only the standard deviations between groups and difference analysis of the mean values were used in the evaluation of the biological relevance
Parameter:
SI
Remarks on result:
other: sensitization was observed at the high dose group, containing 50% compound and the calculated SI value is 26.30%.

Based on results obtained in validation studies and general experiences with this test system groups of mice were treated with vehicle, 2%, 10% or 50% m-dichlorobenzene in A/OO.

 

After treatment with 1,3-dichlorobenzene there was a clear increase compared to control animals regarding the weights of the draining lymph nodes, which is of statistical significance in the high dose group. The "positive level", which is 1.4 for cell counts, has been exceeded in the high dose group.

A sensitizing potential can be assumed from the increases in cell proliferation in the draining lymph nodes. On the basis of the experiences using this method the "positive level" had been set to an increase in cell count index by 0.4 (i.e. index > 1.4), which has been exceeded in the high dose group.

The "positive level" of ear swelling which is 2 x l0E-2 mm increase, i.e. more than 10% increase in index, has not been reached or exceeded.

The EC 1.4 value calculated is 26.30% for this test item. In accordance with the classification proposed in the Technical Report No. 78 of the ECETOC this value corresponds to a weak skin sensitizer.

 

It has to be clarified that the "positive levels" mentioned above are exclusively defined for the NMRI outbreed mice used for this study. Such positive limits have to be calculated for each strain of mice individually.

The body weights of the animals were not affected by any treatment. 

Interpretation of results:
sensitising
Executive summary:

The modified Local Lymph Node Assay (IMDS) was performed on 24 female NMRI mice of the strain Hsd Win:NMRI (6 animals/test item group and 6 control animals) to determine if there is any specific (sensitizing) or non-specific (irritant) stimulating potential of the test item m-dichlorobenzene.

 

The study was conducted according to OECD Guidelines No. 429 and No. 406, EC Guideline 2004/73/EC (29th Adaptation of Guideline 67/548/EEC, B.42)/Health Effects Test Guideline and OPPTS 870.2600 (EPA) with the following test item concentrations:

 

0 (vehicle control), 2, 10 and 50%.

 

The test item was formulated in acetone/olive oil (4:1) (A/OO) to yield a solution.

 

Compared to vehicle treated animals there were clear increases regarding the weights of the draining lymph nodes and the cell counts in the high dose group. These increases are of statistical significance. The "positive level" of index 1.4 for the cell counts was clearly exceeded at the high dose group.

 

The "positive level" of ear swelling, which is 2x10-2mm increase, i.e. about 10% of the control values, has not been reached or exceeded in any dose group.

No substance specific effects were determined for ear weight either.

 

In conclusion, these results show that the test item 1,3-dichlorobenzene has a weak sensitizing potential in mice after dermal application of a 50% concentration.

Therefore, the concentration of 10% turned out to be the NOEL for the parameters investigated in this study with respect to skin sensitization.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

After treatment with 1,3-dichlorobenzene there was a clear increase compared to control animals regarding the weights of the draining lymph nodes, which is of statistical significance in the high dose group; 50%. A modification of the assay by measuring the cell count instead of radioactive labelling was used in this assay to potentially gain information into mechanistic events. The sensitivity of this modification was demonstrated in independent studies referenced in the report. The "positive level" in this modified test, which is 1.4 for cell counts, has been exceeded in the high dose group.

The "positive level" of ear swelling which is 2 x l0E-2 mm increase, i. e. more than 10% increase in index, has not been reached or exceeded and consequently no irritation is assumed.

The EC 1.4 value (corresponding to the SE3 value in radioactive readout) calculated is 26.30% for this test item. In accordance with the classification proposed in the Technical Report No. 78 of the ECETOC this value corresponds to a weak skin sensitizer.



Migrated from Short description of key information:
A modified Local Lymph Node Assay (IMDS) was performed on 24 female NMRI mice of the strain Hsd Win:NMRI (6 animals/test item group and 6 control animals) to determine if there is any specific (sensitizing) or non-specific (irritant) stimulating potential of the test item m-dichlorobenzene.
The study was conducted according to OECD Guidelines No. 429 and No. 406, EC Guideline 2004/73/EC (29th Adaptation of Guideline 67/548/EEC, B.42)/Health Effects Test Guideline and OPPTS 870.2600 (EPA) with the following test item concentrations: 0 (vehicle control), 2, 10 and 50%.

Justification for selection of skin sensitisation endpoint:
key study is used

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

no data


Migrated from Short description of key information:
no data

Justification for classification or non-classification

After treatment with 1,3-dichlorobenzene there was a clear increase compared to control animals regarding the weights of the draining lymph nodes in the high dose group. The "positive level", which is 1.4 for cell counts, has been exceeded in the high dose group.

The "positive level" of ear swelling has not been reached or exceeded.

The EC 1.4 value calculated is 26.30% for this test item. In accordance with the classification proposed in the Technical Report No. 78 of the ECETOC this value corresponds to a weak skin sensitizer.

Therefore a classification as Skin Sens 1B; H317 is justified.